Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Glycosan BioSystems

Glycosan BioSystems
2006 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of formulations of a hyaluronan-based synthetic extracellular matrix. The company offers Extracel and HyStem for stem cell researchers, Extracel-HP and HyStem-HP for applications which require slow release of growth factors in a cell's microenvironment and Extracel-X for growing tumor xenografts in mice.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
OrthoCyte Corp.
Primary Office
  • 675 Arapeen Drive
  • Suite 302
  • Salt Lake City, UT 84108
  • United States

Glycosan BioSystems Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Glycosan BioSystems‘s full profile, request access.

Request full access to PitchBook